Modulating platelet-T cell interactions, intervening in the PSGL-1 axis, reducing PMP-driven inflammation, and accelerating the clearance of exhausted platelets could be critical steps in developing more effective, long-term ITP control strategies. Here, SELPLG is linked to autoimmune thrombocytopenic purpura.